Di Carlo D, Falasca F, Palermo E, Mezzaroma I, et al. Dolutegravir-based regimen for maintenance of viral suppression in people living with HIV: 48-week results in real life setting. AIDS Res Hum Retroviruses 2021 Jan 24. doi: 10.1089/AID.2020.0196.
PMID: 33487130